Immunic AG | WebDisclosure

Basculer en Français

9478	Companies
185489	Keywords
117869	Articles
99348	Press releases

Home
Companies
Immunic AG

PRESS RELEASE

published on 10/22/2024 at 12:30, 1 year 1 month ago

Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis
Immunic announces positive outcome of interim analysis of Phase 3 ENSURE Program for vidofludimus calcium in RMS. Trials recommended to continue unchanged till 2026

Multiple Sclerosis Immunic Vidofludimus Calcium Phase 3 ENSURE Program
BRIEF

published on 09/18/2024 at 12:35, 1 year 2 months ago

Immunic Unveils Promising Vidofludimus Calcium Data at ECTRIMS Congress

Multiple Sclerosis Immunic Vidofludimus Calcium Neuroprotection ECTRIMS 2024
BRIEF

published on 09/18/2024 at 12:35, 1 year 2 months ago

Immunic dévoile des données prometteuses sur le vidofludimus calcique au congrès ECTRIMS

Sclérose En Plaques Neuroprotection Immunique Vidofludimus Calcique ECTRIMS 2024
PRESS RELEASE

published on 09/18/2024 at 12:30, 1 year 2 months ago

Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis
Immunic presents key Vidofludimus Calcium data at the 40th Congress of ECTRIMS, highlighting its therapeutic potential in Multiple Sclerosis. Immunic, Inc. (Nasdaq: IMUX) showcases findings at the conference in Copenhagen, Denmark

Multiple Sclerosis Immunic Vidofludimus Calcium Therapeutic Potential ECTRIMS
BRIEF

published on 09/04/2024 at 12:35, 1 year 3 months ago

Immunic Enrolls First Patient in Phase 2 Trial for Post COVID Syndrome

Clinical Trial Vidofludimus Calcium Post COVID Syndrome Fatigue Treatment Epstein-Barr Virus
BRIEF

published on 09/04/2024 at 12:35, 1 year 3 months ago

Immunic recrute son premier patient pour un essai de phase 2 sur le syndrome post-COVID

Essai Clinique Vidofludimus Calcique Syndrome Post-COVID Traitement De La Fatigue Virus D'Epstein-Barr
PRESS RELEASE

published on 09/04/2024 at 12:30, 1 year 3 months ago

Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome
Immunic announces enrollment of the first patient in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium for Post COVID Syndrome. Study aims to suppress EBV reactivation and fatigue symptoms

Clinical Trial Immunic Vidofludimus Calcium Phase 2 Post COVID Syndrome
BRIEF

published on 08/28/2024 at 12:35, 1 year 3 months ago

Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September

Multiple Sclerosis Immunic Vidofludimus Calcium R&D Day Scientific Conferences
BRIEF

published on 08/28/2024 at 12:35, 1 year 3 months ago

Immunic organise une journée de recherche et développement sur la sclérose en plaques et participe à des conférences scientifiques et d'investisseurs en septembre

Sclérose En Plaques Conférences Scientifiques Journée R&D Immunique Vidofludimus Calcique
PRESS RELEASE

published on 08/28/2024 at 12:30, 1 year 3 months ago

Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September
Immunic to host Multiple Sclerosis R&D Day & participate in conferences. Immunic, Inc. develops oral therapies for autoimmune diseases

Investor Conferences Multiple Sclerosis Immunic R&D Day Scientific Conferences

Accesswire

Published on 12/05/2025 at 16:00, 24 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 39 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 39 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 49 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 59 minutes ago

Usha Resources Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 16:10, 14 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 24 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 24 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 24 minutes ago

Amundi Physical Metals plc: Communiqué de Mise à Disposition du Rapport Financier Semestriel au 30 septembre 2025
Published on 12/05/2025 at 16:00, 24 minutes ago

Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 15:10, 1 hour 13 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 13 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 2 hours 26 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 7 hours 39 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 7 hours 39 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE